Skip to content
Home/Companies/Biotech/Addex Therapeutics

Addex Therapeutics

Biotech·Switzerland·Exited 2012·Held 4yr
Entry
2008
Hold
4yr
Exit
2012

Who owns Addex Therapeutics?

Addex Therapeutics is a Swiss Biotech company, formerly owned by Sofinnova Partners, exited in 2012. No current private equity owner is on file.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Capital VI · 2008 · Life Sciences VC

Key facts

HQSwitzerland
SectorBiotech
Exit Year
2012

More from Sofinnova Capital VI

Other portfolio companies in the same fund.

ABIONYX Pharma
Exited 2020
BiotechFrance· 2010
DBV
Exited 2014
BiotechFrance· 2010
Omthera Pharmaceuticals
Exited 2013
BiotechUS· 2010
to AstraZeneca
Ablynx NV
Exited 2018
BiotechBelgium· 2008
to Sanofi
Movetis
Exited 2010
BiotechBelgium· 2008
to Shire
Noxxon Pharma
Exited 2016
BiotechGermany· 2008

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Addex Therapeutics?

Addex Therapeutics was formerly owned by Sofinnova Partners, exited in 2012. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue